Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

RecruitingOBSERVATIONAL
Enrollment

2,070

Participants

Timeline

Start Date

September 26, 2000

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Neuroblastoma
Interventions
OTHER

Tumor and Marrow Markers

Tumor and Marrow Markers

Trial Locations (1)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

Southern Illinois University

OTHER

collaborator

Spanish National Cancer Center

UNKNOWN

collaborator

St. Jude Children's Research Hospital

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

University of Texas

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER